Related references
Note: Only part of the references are listed.Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection
Tomoki Inagaki et al.
FRONTIERS IN MICROBIOLOGY (2021)
Signaling pathways of EBV-induced oncogenesis
Yin Luo et al.
CANCER CELL INTERNATIONAL (2021)
Kaposi's sarcoma herpesvirus is associated with osteosarcoma in Xinjiang populations
Qian Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States
Ilona Argirion et al.
CANCER (2020)
KSHV requires vCyclin to overcome replicative senescence in primary human lymphatic endothelial cells
Terri A. DiMaio et al.
PLOS PATHOGENS (2020)
The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis
J. Charostad et al.
INFECTIOUS AGENTS AND CANCER (2020)
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
Troy E. Messick et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes
Chong Wang et al.
JOURNAL OF VIROLOGY (2019)
Latency and lytic replication in Epstein-Barr virus-associated oncogenesis
Christian Muenz
NATURE REVIEWS MICROBIOLOGY (2019)
Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features
Erika Hissong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Human herpesvirus-encoded kinase induces B cell lymphomas in vivo
Penny M. Anders et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication
Bizunesh Abere et al.
JOURNAL OF VIROLOGY (2018)
Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
Sana AlQarni et al.
ONCOGENE (2018)
Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination
Xiaolan Liu et al.
CELL DEATH & DISEASE (2018)
Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry
Hua Zhang et al.
NATURE MICROBIOLOGY (2018)
Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus
Jia Chen et al.
NATURE MICROBIOLOGY (2018)
EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers
Joanna B. Wilson et al.
CANCERS (2018)
Epstein Barr Virus-Associated Hodgkin Lymphoma
Antonino Carbone et al.
CANCERS (2018)
Contribution of the KSHV and EBV lytic cycles to tumourigenesis
Oliver Manners et al.
CURRENT OPINION IN VIROLOGY (2018)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers
Lijun Jiang et al.
THERANOSTICS (2018)
The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition
Teresa Amaral et al.
EUROPEAN JOURNAL OF CANCER (2017)
Coordinate Regulation of TET2 and EBNA2 Controls the DNA Methylation State of Latent Epstein-Barr Virus
Fang Lu et al.
JOURNAL OF VIROLOGY (2017)
Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems
John K. C. Chan
MODERN PATHOLOGY (2017)
Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3
Ryan Incrocci et al.
VIROLOGY (2017)
The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target
Bizunesh Abere et al.
PLOS PATHOGENS (2017)
Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency
Giuseppe Mariggio et al.
PLOS PATHOGENS (2017)
Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets
Sohtaro Mine et al.
SCIENTIFIC REPORTS (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Qian Zhang et al.
CELL (2017)
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management
Jorge J. Castillo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Histone Deacetylase Classes I and II Regulate Kaposi's Sarcoma-Associated Herpesvirus Reactivation (vol 88, pg 1281, 2014)
Hye Jin Shin et al.
JOURNAL OF VIROLOGY (2016)
A viral kinase mimics S6 kinase to enhance cell proliferation
Aadra Prashant Bhatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
KSHV Entry and Trafficking in Target CellsHijacking of Cell Signal Pathways, Actin and Membrane Dynamics
Binod Kumar et al.
VIRUSES-BASEL (2016)
The KSHV K1 Protein Modulates AMPK Function to Enhance Cell Survival
Penny M. Anders et al.
PLOS PATHOGENS (2016)
Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis
Shaoni Bhattacharjee et al.
FRONTIERS IN MICROBIOLOGY (2016)
The Role of Gammaherpesviruses in Cancer Pathogenesis
Hem Chandra Jha et al.
PATHOGENS (2016)
Compromised MAPK signaling in human diseases: an update
Eun Kyung Kim et al.
ARCHIVES OF TOXICOLOGY (2015)
The biology and treatment of plasmablastic lymphoma
Jorge J. Castillo et al.
BLOOD (2015)
EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment
Alina Nicolae et al.
BLOOD (2015)
Epstein-Barr virus-positive diffuse large B-cell Lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell Lymphoma of the elderly
Stefania Uccini et al.
HUMAN PATHOLOGY (2015)
K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus
Lisa Steinbrueck et al.
JOURNAL OF VIROLOGY (2015)
Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis
Yu-Pei Chen et al.
ONCOTARGET (2015)
EBNA3C regulates p53 through induction of Aurora kinase B
Hem C. Jha et al.
ONCOTARGET (2015)
A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease
Frits van Rhee et al.
ONCOTARGET (2015)
Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression
Lu Dai et al.
ONCOTARGET (2015)
Inhibiting the Recruitment of PLCγ1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial Cells
Silvia Gramolelli et al.
PLOS PATHOGENS (2015)
Systemic Expression of Kaposi Sarcoma Herpesvirus (KSHV) Vflip in Endothelial Cells Leads to a Profound Proinflammatory Phenotype and Myeloid Lineage Remodeling In Vivo
Gianna Ballon et al.
PLOS PATHOGENS (2015)
EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
J. Y. Hong et al.
ANNALS OF ONCOLOGY (2015)
Dual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma
Penny Anders et al.
LEUKEMIA & LYMPHOMA (2015)
EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management
Chi Young Ok et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Diverse Clinicopathologic Features in Human Herpesvirus 8-Associated Lymphomas Lead to Diagnostic Problems
Elizabeth L. Courville et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Clinicopathologic Comparison of Plasmablastic Lymphoma in HIV-positive, Immunocompetent, and Posttransplant Patients Single-center Series of 25 Cases and Meta-analysis of 277 Reported Cases
Julie Morscio et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Cytotoxic T-cell and NK-cell Lymphomas
Steven H. Swerdlow et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era
Ai Sato et al.
CANCER SCIENCE (2014)
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis
M. Constanza Camargo et al.
GUT (2014)
Human Herpesvirus 8 Interleukin-6 Contributes to Primary Effusion Lymphoma Cell Viability via Suppression of Proapoptotic Cathepsin D, a Cointeraction Partner of Vitamin K Epoxide Reductase Complex Subunit 1 Variant 2
Daming Chen et al.
JOURNAL OF VIROLOGY (2014)
Regulation of Epstein-Barr virus reactivation from latency
Takayuki Murata
MICROBIOLOGY AND IMMUNOLOGY (2014)
Kaposi's sarcoma-associated herpesvirus G-protein coupled receptor activates the canonical Wnt/β-catenin signaling pathway
Magdalena Angelova et al.
VIROLOGY JOURNAL (2014)
Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in Malawi
W. Thomas Johnston et al.
SCIENTIFIC REPORTS (2014)
LANA Binds to Multiple Active Viral and Cellular Promoters and Associates with the H3K4Methyltransferase hSET1 Complex
Jianhong Hu et al.
PLOS PATHOGENS (2014)
Extranodal NK/T-cell Lymphoma, Nasal Type A Report of 73 Cases at MD Anderson Cancer Center
Shaoying Li et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
HHV-8-positive but EBV-negative primary effusion lymphoma
Joo Y. Song et al.
BLOOD (2013)
Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies
Utthara Nayar et al.
BLOOD (2013)
Human herpesvirus 8+polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients
Eric Oksenhendler et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Viral Genome Methylation Differentially Affects the Ability of BZLF1 versus BRLF1 To Activate Epstein-Barr Virus Lytic Gene Expression and Viral Replication
Coral K. Wille et al.
JOURNAL OF VIROLOGY (2013)
Efficient Replication of Epstein-Barr Virus-Derived Plasmids Requires Tethering by EBNA1 to Host Chromosomes
Theresa L. Hodin et al.
JOURNAL OF VIROLOGY (2013)
Activation of Human Herpesvirus Replication by Apoptosis
Alka Prasad et al.
JOURNAL OF VIROLOGY (2013)
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors
Daan Dierickx et al.
LEUKEMIA & LYMPHOMA (2013)
Epigenetic diversity of Kaposi's sarcoma-associated herpesvirus
Russell P. Darst et al.
NUCLEIC ACIDS RESEARCH (2013)
Inactivation of Intergenic Enhancers by EBNA3A Initiates and Maintains Polycomb Signatures across a Chromatin Domain Encoding CXCL10 and CXCL9
Marie L. Harth-Hertle et al.
PLOS PATHOGENS (2013)
A Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA Proteins
Jan Hellert et al.
PLOS PATHOGENS (2013)
Molecular Basis for Oligomeric-DNA Binding and Episome Maintenance by KSHV LANA
John F. Domsic et al.
PLOS PATHOGENS (2013)
Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis
Sandrine Sander et al.
CANCER CELL (2012)
Contributions of the Epstein-Barr Virus EBNA1 Protein to Gastric Carcinoma
Nirojini Sivachandran et al.
JOURNAL OF VIROLOGY (2012)
Changes in the Nasopharyngeal Carcinoma Nuclear Proteome Induced by the EBNA1 Protein of Epstein-Barr Virus Reveal Potential Roles for EBNA1 in Metastasis and Oxidative Stress Responses
Jennifer Yinuo Cao et al.
JOURNAL OF VIROLOGY (2012)
Epstein-Barr Virus-Encoded Latent Membrane Protein 1 (LMP1) and LMP2A Function Cooperatively To Promote Carcinoma Development in a Mouse Carcinogenesis Model
Kathy H. Y. Shair et al.
JOURNAL OF VIROLOGY (2012)
An Alternative Kaposi's Sarcoma-Associated Herpesvirus Replication Program Triggered by Host Cell Apoptosis
Alka Prasad et al.
JOURNAL OF VIROLOGY (2012)
Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Monocytes Downregulates Expression of Adaptive Immune Response Costimulatory Receptors and Proinflammatory Cytokines
Sean M. Gregory et al.
JOURNAL OF VIROLOGY (2012)
Sustained Remission of Multicentric Castleman Disease in Children Treated with Tocilizumab, an Anti-Interleukin-6 Receptor Antibody
Caroline Galeotti et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The genetic landscape of mutations in Burkitt lymphoma
Cassandra Love et al.
NATURE GENETICS (2012)
The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma-associated herpesvirus
Alexander S. Hahn et al.
NATURE MEDICINE (2012)
Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma
Aadra P. Bhatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection
Sayan Chakraborty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
Simon Jochum et al.
PLOS PATHOGENS (2012)
Epstein-Barr Virus-positive Diffuse Large B-cell Lymphomas of the Elderly
Patrick Adam et al.
ADVANCES IN ANATOMIC PATHOLOGY (2011)
Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells
Chiaki Saji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma
Stefan D. Dojcinov et al.
BLOOD (2011)
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy
Thomas S. Uldrick et al.
BLOOD (2011)
Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma
T. Horikawa et al.
BRITISH JOURNAL OF CANCER (2011)
Oncogenic AKTivation of translation as a therapeutic target
A. C. Hsieh et al.
BRITISH JOURNAL OF CANCER (2011)
PI3Kγ Mediates Kaposi's Sarcoma-Associated Herpesvirus vGPCR-Induced Sarcomagenesis
Daniel Martin et al.
CANCER CELL (2011)
EBV-Positive Diffuse Large B-Cell Lymphoma in Young Immunocompetent Individuals
Brady E. Beltran et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice
Gianna Ballon et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Lymphocyte-Depleted Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group
Beate Klimm et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
Shi-Dong Ma et al.
JOURNAL OF VIROLOGY (2011)
Amplification of the Angiogenic Signal through the Activation of the TSC/mTOR/HIF Axis by the KSHV vGPCR in Kaposi's Sarcoma
Bruno C. Jham et al.
PLOS ONE (2011)
Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth
Bo Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression
Seiji Maruo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin
Jie Lu et al.
VIROLOGY (2011)
Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells
Jinjong Myoung et al.
VIROLOGY (2011)
Restricted Kaposi's Sarcoma (KS) Herpesvirus Transcription in KS Lesions from Patients on Successful Antiretroviral Therapy
Dirk P. Dittmer
MBIO (2011)
Epstein-Barr Virus Nuclear Antigen 3C Stabilizes Gemin3 to Block p53-mediated Apoptosis
Qiliang Cai et al.
PLOS PATHOGENS (2011)
Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas
Aadra P. Bhatt et al.
BLOOD (2010)
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
Soken-Nakazawa J. Song et al.
BLOOD (2010)
Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis
Mrinal Samanta et al.
CANCER SCIENCE (2010)
Viral Latency and Its Regulation: Lessons from the γ-Herpesviruses
Samuel H. Speck et al.
CELL HOST & MICROBE (2010)
The Latent Origin of Replication of Epstein-Barr Virus Directs Viral Genomes to Active Regions of the Nucleus
Manuel J. Deutsch et al.
JOURNAL OF VIROLOGY (2010)
The Viral Latency-Associated Nuclear Antigen Augments the B-Cell Response to Antigen In Vivo
Sang-Hoon Sin et al.
JOURNAL OF VIROLOGY (2010)
Array-Based Transcript Profiling and Limiting-Dilution Reverse Transcription-PCR Analysis Identify Additional Latent Genes in Kaposi's Sarcoma-Associated Herpesvirus
Sanjay Chandriani et al.
JOURNAL OF VIROLOGY (2010)
Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation
Robert Valentine et al.
MOLECULAR CANCER (2010)
Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1
K. W. Wen et al.
ONCOGENE (2010)
Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual Screening
Ning Li et al.
PLOS ONE (2010)
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma
Kristopher A. Sarosiek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The phosphatase Shp2 is required for signaling by the Kaposi's sarcoma-associated herpesvirus viral GPCR in primary endothelial cells
Thomas Bakken et al.
VIROLOGY (2010)
Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1)
Fang Lu et al.
VIROLOGY JOURNAL (2010)
Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-κB activation
Yoon-Jae Song et al.
VIRUS GENES (2010)
Nucleophosmin Phosphorylation by v-Cyclin-CDK6 Controls KSHV Latency
Grzegorz Sarek et al.
PLOS PATHOGENS (2010)
Cyclin-Dependent Kinase-Like Function Is Shared by the Beta- and Gamma- Subset of the Conserved Herpesvirus Protein Kinases
Chad V. Kuny et al.
PLOS PATHOGENS (2010)
Epigenetic Repression of p16(INK4A) by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP
Lenka Skalska et al.
PLOS PATHOGENS (2010)
Meta-analysis Shows That Prevalence of Epstein-Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic Location
Gwen Murphy et al.
GASTROENTEROLOGY (2009)
Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2)
Vipra Kapur Nayyar et al.
JOURNAL OF CELL SCIENCE (2009)
Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
Dai Iwakiri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma
Katherine Cosmopoulos et al.
JOURNAL OF VIROLOGY (2009)
Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2
Abhik Saha et al.
JOURNAL OF VIROLOGY (2009)
Role for G-Quadruplex RNA Binding by Epstein-Barr Virus Nuclear Antigen 1 in DNA Replication and Metaphase Chromosome Attachment
Julie Norseen et al.
JOURNAL OF VIROLOGY (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
FLIP-mediated autophagy regulation in cell death control
Jong-Soo Lee et al.
NATURE CELL BIOLOGY (2009)
EBNA1 regulates cellular gene expression by binding cellular promoters
Allon Canaan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins αvβ6 or αvβ8
Liudmila S. Chesnokova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities
Fuming Yi et al.
VIROLOGY (2009)
Survival advantage of ERV-associated gastric carcinoma: Survivin up-regulation by viral latent membrane protein 2A
Rumi Hino et al.
CANCER RESEARCH (2008)
EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration
Kathy H. Y. Shair et al.
CANCER RESEARCH (2008)
Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: Special references to lymphomas surrounding this newly recognized clinicopathologic disease
Yoshie Shimoyama et al.
CANCER SCIENCE (2008)
Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology
Efsevia Vakiani et al.
HEMATOLOGICAL ONCOLOGY (2008)
The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype
M. Vockerodt et al.
JOURNAL OF PATHOLOGY (2008)
Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn
Mark Rovedo et al.
JOURNAL OF VIROLOGY (2008)
Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice
Myung-Soo Kang et al.
JOURNAL OF VIROLOGY (2008)
Epstein-Barr Nuclear Antigen 1 Contributes to Nasopharyngeal Carcinoma through Disruption of PML Nuclear Bodies
Nirojini Sivachandran et al.
PLOS PATHOGENS (2008)
An NF-κB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia
D. Martin et al.
ONCOGENE (2008)
Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders
J. Borenstein et al.
HISTOPATHOLOGY (2007)
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
Christoph Mancao et al.
BLOOD (2007)
Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated notch by targeting the Sel10 protein
Ke Lan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Modulation of LMP1 protein expression by EBV-encoded microRNAs
Angela Kwok Fung Lo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Epstein-Barr virus (EBV)-Encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-Induced B-Cell growth transformation
Yi Wu et al.
JOURNAL OF VIROLOGY (2007)
The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc
Jianyong Liu et al.
JOURNAL OF VIROLOGY (2007)
Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/P13-K/Akt pathway
Makoto Fukuda et al.
JOURNAL OF VIROLOGY (2007)
Age-related EBV-Associated B-Cell Lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients
Takashi Oyama et al.
CLINICAL CANCER RESEARCH (2007)
Unique signaling properties of CTAR1 in LMP1-Mediated transformation
Bernardo A. Mainou et al.
JOURNAL OF VIROLOGY (2007)
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen
D. Bubman et al.
ONCOGENE (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
AIDS-Related cancer and severity of immunosuppression in persons with AIDS
Robert J. Biggar et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways
V. H. J. Wood et al.
ONCOGENE (2007)
Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells
Amanda Dutton et al.
BLOOD (2007)
K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis
Suizhao Wang et al.
BLOOD (2007)
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
Sang-Hoon Sin et al.
BLOOD (2007)
Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes
Wangrong Wen et al.
JOURNAL OF VIROLOGY (2007)
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: A cell and animal model of virally induced Kaposi's sarcoma
Agata D'Agostino Mutlu et al.
CANCER CELL (2007)
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
Robert J. Biggar et al.
BLOOD (2006)
Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays
Andrew I. Bell et al.
JOURNAL OF GENERAL VIROLOGY (2006)
The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor
Akrit Sodhi et al.
CANCER CELL (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice
Christopher H. Parsons et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster
Muzammel Haque et al.
JOURNAL OF VIROLOGY (2006)
Activation of NF-κB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype
Claudia Grossmann et al.
JOURNAL OF VIROLOGY (2006)
Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling
V Fok et al.
JOURNAL OF CELL BIOLOGY (2006)
Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22
V Fok et al.
RNA (2006)
NF-κB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
SA Keller et al.
BLOOD (2006)
Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus
L Wang et al.
CANCER RESEARCH (2006)
Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: Cystine transporter xCT
JAR Kaleeba et al.
SCIENCE (2006)
Virus and cell RNAs expressed during Epstein-Barr virus replication
J Yuan et al.
JOURNAL OF VIROLOGY (2006)
The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma
FD Fakhari et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities
M Djokic et al.
GENES CHROMOSOMES & CANCER (2006)
DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages
G Rappocciolo et al.
JOURNAL OF IMMUNOLOGY (2006)
Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells
HH Krishnan et al.
JOURNAL OF VIROLOGY (2006)
Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells
M Hong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling
I Guasparri et al.
EMBO REPORTS (2006)
Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K
BA Mainou et al.
ONCOGENE (2005)
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease
N Nishimoto et al.
BLOOD (2005)
Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome
BS Lee et al.
JOURNAL OF VIROLOGY (2005)
ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection
N Sharma-Walia et al.
JOURNAL OF VIROLOGY (2005)
Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders:: Correlation with histopathological subcategories and EBV status
HA Poirel et al.
TRANSPLANTATION (2005)
Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS
E Boulanger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles
F Vega et al.
MODERN PATHOLOGY (2005)
Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro
A Chen et al.
JOURNAL OF VIROLOGY (2005)
Sirolimus for Kaposi's sarcoma in renal-transplant recipients
G Stallone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma
KK Jensen et al.
JOURNAL OF IMMUNOLOGY (2005)
Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines
D Iwakiri et al.
ONCOGENE (2005)
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes
KCM Straathof et al.
BLOOD (2005)
Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: Are they two different diseases?
IM Ghobrial et al.
TRANSPLANTATION (2005)
Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice
MS Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus
PP Naranatt et al.
JOURNAL OF VIROLOGY (2005)
Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor
A Sodhi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
KSHV vFLIP is essential for the survival of infected lymphoma cells
I Guasparri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-Rho GTPase signal pathways and cytoskeletal rearrangements
N Sharma-Walia et al.
JOURNAL OF VIROLOGY (2004)
Role of NF-κB in cell survival and transcription of latent membrane protein 1 -: Expressing or Epstein-Barr virus latency III-infected cells
ED Cahir-McFarland et al.
JOURNAL OF VIROLOGY (2004)
Conversion to sirolimus: A successful treatment for posttransplantation Kaposi's sarcoma
JM Campistol et al.
TRANSPLANTATION (2004)
B cell receptor signal strength determines B cell fate
S Casola et al.
NATURE IMMUNOLOGY (2004)
The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway
CC Tomlinson et al.
JOURNAL OF VIROLOGY (2004)
Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation
CW Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression
JF Gera et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of p53 in suppression of KSHV cyclin-induced lymphomagenesis
EW Verschuren et al.
CANCER RESEARCH (2004)
ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway
MS Hamza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction
LX Yang et al.
CANCER RESEARCH (2004)
Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?
CA van den Bosch
LANCET ONCOLOGY (2004)
Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation
DN Everly et al.
JOURNAL OF VIROLOGY (2004)
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway
T Portis et al.
ONCOGENE (2004)
Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: Insights into modulation events early during infection
PP Naranatt et al.
CANCER RESEARCH (2004)
The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia
S Montaner et al.
BLOOD (2004)
KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma
A Chadburn et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma
N Heussinger et al.
JOURNAL OF PATHOLOGY (2004)
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities
L Colomo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells
HM Li et al.
ONCOGENE (2004)
Four EBNA2 domains are important for EBNALP coactivation
CW Peng et al.
JOURNAL OF VIROLOGY (2004)
Epstein-Barr virus provides a survival factor to Burkitt's lymphomas
G Kennedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of mitogen-activated protein kinase and NF-κB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein
MM Brinkmann et al.
JOURNAL OF VIROLOGY (2003)
Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7
MN Holowaty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5
N Ohtani et al.
JOURNAL OF CELL BIOLOGY (2003)
Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis
SM Akula et al.
JOURNAL OF VIROLOGY (2003)
EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes
P Kapoor et al.
JOURNAL OF VIROLOGY (2003)
Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression:: the role of the NF-κB and JNK/AP1 pathways
JB An et al.
ONCOGENE (2003)
Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: A role for Kaposi's sarcoma-associated herpesvirus
EA Engels et al.
MODERN PATHOLOGY (2003)
Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines
JS Knight et al.
JOURNAL OF VIROLOGY (2003)
A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency
M Fujimuro et al.
NATURE MEDICINE (2003)
Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR
C Bais et al.
CANCER CELL (2003)
Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse
HG Guo et al.
JOURNAL OF VIROLOGY (2003)
Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: Implications for infectivity
PP Naranatt et al.
JOURNAL OF VIROLOGY (2003)
EBNA3A association with RBP-J kappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth
A Cooper et al.
JOURNAL OF VIROLOGY (2003)
Senile EBV plus B-cell Lymphoproliferative disorders - A clinicopathologic study of 22 patients
T Oyama et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminalbinding protein (CtBP)
M Hickabottom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns
A Franchi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
KSHV- and EBV-associated germinotropic lymphoproliferative disorder
MQ Du et al.
BLOOD (2002)
Pyothorax-associated lymphoma: A review of 106 cases
S Nakatsuka et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo
EW Verschuren et al.
CANCER CELL (2002)
Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases
DV Ablashi et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the IκB kinase complex
L Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
MY Li et al.
NATURE (2002)
High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease
E Oksenhendler et al.
BLOOD (2002)
Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via Gi and phospholipase C-dependent signaling pathways
MJ Smit et al.
JOURNAL OF VIROLOGY (2002)
The LMP2a signalosome - A therapeutic target for Epstein-Barr virus latency and associated disease
T Portis et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element
JB An et al.
BLOOD (2002)
The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration
C Subramanian et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
Characterization of gamma 2-human herpesvirus-8 glycoproteins gH and gL
PP Naranatt et al.
ARCHIVES OF VIROLOGY (2002)
Association of Epstein-Barr virus and nasopharyngeal carcinoma in caucasian patients
G Plaza et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2002)
Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma
A Nanbo et al.
EMBO JOURNAL (2002)
K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function
TV Sharp et al.
JOURNAL OF VIROLOGY (2002)
Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1
H Wu et al.
JOURNAL OF VIROLOGY (2002)
Effect of transforming growth factor-β1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines
M Fukuda et al.
VIROLOGY (2001)
Activation of NF-κB by the human herpesvirus 8 chemokine receptor ORF74:: Evidence for a paracrine model of Kaposi's sarcoma pathogenesis
S Pati et al.
JOURNAL OF VIROLOGY (2001)
Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties
SM Akula et al.
VIROLOGY (2001)
Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma
J Kapelushnik et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR
ML Dykstra et al.
IMMUNITY (2001)
Epstein-Barr virus-encoded poly(A)- RNA supports Burkitt's lymphoma growth through interleukin-10 induction
N Kitagawa et al.
EMBO JOURNAL (2000)
Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt
F Scholle et al.
JOURNAL OF VIROLOGY (2000)
The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2
PM Ojala et al.
NATURE CELL BIOLOGY (2000)
Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2
DY Wu et al.
JOURNAL OF VIROLOGY (2000)
The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells
SA Radkov et al.
NATURE MEDICINE (2000)
LMP2A ITAM is essential for providing B cells with development and survival signals in vivo
M Merchant et al.
JOURNAL OF VIROLOGY (2000)
Epstein-Barr virus infection.
JI Cohen
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Epstein-Barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an Spi-1/Spi-B binding site
B Zhao et al.
JOURNAL OF VIROLOGY (2000)
CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas
A Dogan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease
H Katano et al.
VIROLOGY (2000)
Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 36 protein is a serine protein kinase
J Park et al.
JOURNAL OF GENERAL VIROLOGY (2000)
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma
N Dupin et al.
BLOOD (2000)
Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma
TY Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis
GA Parker et al.
ONCOGENE (2000)
Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EμLMP2A transgenic mice
RG Caldwell et al.
JOURNAL OF VIROLOGY (2000)
Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2
LJ Strobl et al.
JOURNAL OF VIROLOGY (2000)
The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases
M Ikeda et al.
VIROLOGY (2000)
Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome
JK Choi et al.
JOURNAL OF VIROLOGY (2000)
Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor
KM Haan et al.
JOURNAL OF VIROLOGY (2000)
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders - A distinct entity?
BP Nelson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
Share Paper
